Role of tumor suppressor genes in transplacental lung carcinogenesis

Molecular Carcinogenesis

Volumn 21, Issue 3, 1998, Pages 177-184

  Rollins, Lisa A ^a   Leone Kabler, Sandra ^a   O'Sullivan, M Gerard ^a   Miller, Mark Steven ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cdkn2a; Ki ras 2; Non small cell lung cancer; p53; Retinoblastoma gene

Indexed keywords

3 METHYLCHOLANTHRENE;

ANIMAL TISSUE; ARTICLE; CANCER RISK; EXON; GENE LOCUS; GENETIC ANALYSIS; GENETIC POLYMORPHISM; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MOUSE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PLACENTAL TRANSFER; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ANIMALS; CARCINOGENS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; EXONS; FEMALE; GENES, P53; GENES, RAS; GENES, RETINOBLASTOMA; GENES, TUMOR SUPPRESSOR; INTRONS; LUNG NEOPLASMS; MALE; METHYLCHOLANTHRENE; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS;

ANIMALIA; MURINAE;

EID: 0031969203     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2744(199803)21:3<177::AID-MC5>3.0.CO;2-J     Document Type: Article

References (48)

1. Carbone DP, Minna JD. The molecular genetics of lung cancer. In: Stollerman GH, LaMont JT, Leonard JJ, Siperstein MD, (eds), Advances in Internal Medicine, vol. 37, Mosby Year Book, Inc., St. Louis, MO, 1992, pp. 153-171.
2. Levine AJ. p53, the cellular gatekeeper for growth and cell division. Cell 88:323-331, 1997.
3. Paulovich AG, Toczyski DP, Hartwell LH. When checkpoints fail. Cell 88:315-321, 1997.
4. Greenblatt MS, Bennet WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res 54:4855-4878, 1994.
5. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707, 1993.
6. INK4 gene mediated by an adenovirus vector. Cancer Res 55:3250-3253, 1995.
7. Lukas J, Parry D, Aagaard L, et al. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature 375:503-506, 1995.
8. ink4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 92:6289-6293, 1995.
9. Khleif SN, DeGregori J, Yee CL, et al. Inhibition of cyclin D-CDK4/ CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity. Proc Natl Acad Sci USA 93:4350-4354, 1996.
10. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 81:323-330, 1995.
11. Sherr CJ. Cancer cell cycles. Science 274:1672-1677, 1996.
12. Serrano M, Lee H, Chin L, Cordon-Cardo C, Beach D, DePinho RA. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85:27-37, 1996.
13. INK4 in human cancer. Proc Natl Acad Sci USA 91:11045-11049, 1994.
14. INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Oncogene 9:3375-3378, 1994.
15. INK4a expression in primary lung cancers and cell lines. Cancer Res 55:505-509, 1995.
16. INK4a expression in resected non-small cell lung tumors. Cancer Res 56:3415-3420, 1996.
17. Miller MS. Transplacental lung carcinogenesis: A pharmacogenetic mouse model for the modulatory role of cytochrome P450 1A1 on lung cancer. Chem Res Toxicol 7:471-481, 1994.
18. Bunin GR, Kramer S, Marrero O, Meadows AT. Gestational risk factors for Wilms' tumor: Results of a case-control study. Cancer Res 47:2972-2977, 1987.
19. Stjernfeldt M, Berglund K, Lindsten J, Ludvigsson J. Maternal smoking during pregnancy and risk of childhood cancer. Lancet 1:1350-1352, 1986.
20. John EM, Savitz DA, Sandler DP. Prenatal exposure to parents' smoking and childhood cancer. Am J Epidemiol 133:123-132, 1991.
21. Sandler DP, Everson RB, Wilcox AJ, Browder JP. Cancer risk in adulthood from early life exposure to parents' smoking. Am J Public Health 75:487-492, 1985.
22. Hatch MC, Warburton D, Santella RM. Polycyclic aromatic hydrocarbon-DNA adducts in spontaneously aborted fetal tissue. Carcinogenesis 11:1673-1675, 1990.
23. Hansen C, Sørensen LD, Asmussen I, Autrup H. Transplacental exposure to tobacco smoke in human-adduct formation in placenta and umbilical cord blood vessels. Teratog Carcinog Mutagen 12:51-60, 1992.
24. Manchester DK, Bowman ED, Parker NB, Caporaso NE, Weston A. Determinants of polycyclic aromatic hydrocarbon-DNA adducts in human placenta. Cancer Res 52:1499-1503, 1992.
25. Whyatt RM, Garte SJ, Cosma G, et al. CYP1A1 messenger RNA levels in placental tissue as a biomarker of environmental exposure. Cancer Epidemiol Biomarkers Prev 4:147-153, 1995.
26. Anderson LM, Jones AB, Riggs CW, Ohshima M. Fetal mouse susceptibility to transplacental lung and liver carcinogenesis by 3-methylcholanthrene: Positive correlation with responsiveness to inducers of aromatic hydrocarbon metabolism. Carcinogenesis 6:1389-1393, 1985.
27. Wessner LL, Fan M, Schaeffer DO, McEntee MF, Miller MS. Mouse lung tumors exhibit specific Ki-ras mutations following transplacental exposure to 3-methylcholanthrene. Carcinogenesis 17:1519-1526, 1996.
28. Miller MS, Jones AB, Chauhan DP, Park SS, Anderson LM. Differential induction of fetal mouse liver and lung cytochromes P-450 by β-naphthoflavone and 3-methylcholanthrene. Carcinogenesis 10:875-883, 1989.
29. Miller MS, Jones AB, Chauhan DP, Anderson LM. Role of the maternal environment in determining susceptibility to transplacentally induced chemical carcinogenesis in mouse fetuses. Carcinogenesis 11:1979-1984, 1990.
30. Miller MS, Jones AB, Anderson LM. The formation of 3-methylcholanthrene-initiated lung tumors correlates with induction of cytochrome CYPIA1 by the carcinogen in fetal but not adult mice. Toxicol Appl Pharmacol 104:235-245, 1990.
31. Leone-Kabler S, Wessner LL, McEntee MF, D'Agostino RB, Miller MS. Ki-ras mutations are an early event and correlate with tumor stage in transplacentally induced murine lung tumors. Carcinogenesis 18:1163-1168, 1997.
32. Reynolds SH, Wiest JS, Devereux TR, Anderson MW, You M. Protooncogene activation in spontaneously occurring and chemically induced rodent and human lung tumors. In: Klein-Szanto AJP. Anderson MW, Barrett JC, Slaga TJ (eds), Comparative Molecular Carcinogenesis, Wiley-Liss, Inc., New York, 1992, pp. 303-320.
33. 33: Conti CJ. Mutations of genes of the ras family in human and experimental tumors. In: Klein-Szanto AJP, Anderson MW, Barrett JC, Slaga TJ, (eds). Comparative Molecular Carcinogenesis, Wiley-Liss, Inc., New York, 1992, pp. 357-378.
34. Wright DK, Manos MM. Sample preparation from paraffin-embedded tissues. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ, (eds). PCR Protocols: A Guide to Methods and Applications, Academic Press, Inc., San Diego, 1990, pp. 153-158.
35. Saiki RK, Gelfand DH, Stoffel S, et al. Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239:487-491, 1988.
36. Hegi ME, Söderkvist P, Foley JF, et al. Characterization of p53 mutations in methylene chloride-induced lung tumors from B6C3F1 mice. Carcinogenesis 14:803-810, 1993.
37. MacDonald RJ, Swift GH, Przybyla AE, Chirgwin JM. Isolation of RNA using guanidinium salts. Methods Enzymol 152:219-227, 1987.
38. Thomas PS. Hybridization of denatured RNA transferred or dotted to nitrocellulose paper. Methods Enzymol 100:255-266, 1983.
39. Baker S, Markowitz S, Fearon ER, Willson JKV, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915, 1990.
40. Tso JY, Sun X-H, Kao T, Reece KS, Wu R. Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: Genomic complexity and molecular evolution of the gene. Nucleic Acids Res 13:2485-2502, 1985.
41. Geradts J, Hu SX, Lincoln CE, Benedict WF, Xu HJ. Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int J Cancer 58:161-167, 1994.
42. Beenken SW, Karsenty G, Raycroft L, Lozano G. An intron binding protein is required for transformation ability of p53. Nucleic Acids Res 19:4747-4752, 1991.
43. INK4b genes. Oncogene 11:635-645, 1995.
44. INk4a-β in mouse lung tumor cells. Oncogene 13:1885-1891, 1996.
45. Re FC, Manenti G, Borrello MG, et al. Multiple molecular alterations in mouse lung tumors. Mol Carcinog 5:155-160, 1992.
46. INK4a alterations in 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumorigenesis. Proceedings of the American Association for Cancer Research 38:3135, 1997.
47. Hegi ME, Devereux TR, Dietrich WF, et al. Allelotype analysis of mouse lung carcinomas reveals frequent allelic losses on chromosome 4 and an association between allelic imbalances on chromosome 6 and K-ras activation. Cancer Res 54:6257-6264, 1994:
48. INK4a. Cell 88:593-602, 1997.